Physician Lab-Referral Bonuses: When Compensation Counts the Tests Ordered

A physician laboratory referral bonus can violate the Stark Law when it pays a doctor for tests ordered through a practice that bills Medicare. The compensation formula puts the conflict on paper: the physician chooses the testing, the practice collects the payment, and part of the value returns to the physician. If you work with those orders or calculate those bonuses, you may see the connection that the claim alone leaves out.

When the Bonus Follows the Laboratory Order

A physician employee bonus for ordering more laboratory tests connects the doctor’s income to the ordering decision. The useful question is what earns the money: work the physician performs, profits from a laboratory, or the value of tests the physician sends there.

The Centers for Medicare & Medicaid Services’ explanation of the physician self-referral law says Stark restricts Medicare referrals to a laboratory where the doctor has a financial tie, whether through pay, ownership or investment. We examine that tie and whether an exception applies.

The agency uses the phrase volume or value of referrals when discussing how compensation is calculated. In a laboratory bonus formula, that means looking at whether pay follows how many tests a doctor orders or how much business those orders generate.

The paperwork can contain different kinds of incentive within the same employment arrangement. A whistleblower complaint against Surgery Partners described an initial productivity bonus based on surgical work the physician personally performed, followed by eligibility for compensation tied to ancillary-service collections. Its allegation about laboratory profits was explicit:

The distinction is in the calculation. A payroll label such as productivity does little to explain which services generated the payment. The employment agreement and its ancillary-service schedule show what the company promised to count.

What the Order and Claim Show

The order, the test performed and the claim show how a compensation incentive reaches the payer. The bonus calculation adds the return payment to the person choosing the testing. We examine those records together, including who selected the panel and which laboratory performed and billed it.

A separate whistleblower complaint concerning Logan Laboratories alleged that the NextGen electronic records system automatically paired a drug screen with a 32-panel confirmation for all patients, without customization options or a choice of laboratory. It also alleged that physicians signed authorizations for a predefined panel lasting a year. The system settings and the standing authorization each help explain how an order reached the lab.

In the Surgery Partners complaint, whistleblowers also alleged that executives tracked confirmation referrals by provider and circulated reports to pressure providers to send more testing to Logan. That gives an insider something more specific than a general instruction to increase revenue: the company allegedly measured the very referral that generated the laboratory’s income.

Requisition design has been a recognized issue for decades. Model Plan Helps Laboratories Fight Fraud, published in Laboratory Medicine in 1997, described forms with space to document the medical necessity of each test, physician acknowledgments for customized profiles and monitoring of standing orders. Those details connect the practice’s clinical choices to the laboratory’s work. In a referral-bonus case, we also connect them to the compensation records.

What the Physician Compensation Cases Show

The cases show different ways to put money behind a referral: a share of ordered tests and revenue from another category of patients. Each arrangement leaves a different paper trail.

Family Medicine Centers and Tests Personally Ordered

Family Medicine Centers of South Carolina agreed in 2017 to pay $1.56 million to settle False Claims Act allegations. The physician-owned chain operated family medicine clinics around Columbia. The government alleged that its incentive plan paid physicians a percentage of the value of laboratory and other diagnostic tests they personally ordered through the practice, which then billed Medicare.

The alleged management message matched the formula. The chief executive allegedly reminded physicians to order tests and other services through the practice to increase its profits and maintain their high take-home pay. The alleged bargain put patients through unnecessary testing and left taxpayers funding the doctors’ higher take-home pay.

The settlement also covered allegations of unnecessary laboratory services billed to Medicare and TRICARE. The government described custom panels containing tests inappropriate for routine measurement, tests performed without a treating physician’s order, standing orders driven by a fixed frequency and billing software programmed to change codes to secure Medicare payment. A physician formerly employed by the practice brought the whistleblower case.

Advanced Pain Management and Urine Drug Testing

The Justice Department’s 2020 announcement described Advanced Pain Management’s $885,452 settlement with the United States, which included allegations of unnecessary confirmatory urine drug testing. Providers allegedly failed to tailor orders to individual patients’ risks and circumstances, producing more testing than the medical records supported. The company disclosed those testing claims.

Oaktree, Labsource and Commercial Testing Revenue

The Oaktree Medical Centre and Labsource matter joined allegations of financial incentives for urine drug testing with allegations of unnecessary tests. In 2021, the government obtained $140 million in civil judgments against the clinic and laboratory businesses.

The owner’s later civil resolution made one incentive concrete. As the Justice Department described in its announcement of the civil consent judgment and criminal plea, he admitted that Labsource offered providers revenue from commercially insured urine drug testing to induce them to send their federally insured patients there too. The admission about that direct-bill arrangement came in the civil resolution. In his separate criminal plea, he admitted conspiring to pay illegal kickbacks and bill health care programs for unnecessary medical services.

The payment opportunity and the government claim could sit in different payer accounts. The admitted arrangement used one to obtain the other. A review limited to the Medicare payment would miss the commercial revenue offered to secure the referral.

Do Doctors Get Kickbacks for Ordering Tests?

Yes. Laboratory cases describe payments to physicians for test referrals, including a percentage of the lab’s reimbursements. In a criminal case involving a co-owner of Louisiana Spine & Sports, the doctor pleaded guilty to a kickback conspiracy. Court documents described an agreement to send patient urine specimens to a laboratory in exchange for a percentage of reimbursements from Medicare and other healthcare programs.

We examine what the plan paid for, why the payment was offered and which claims followed it, with whistleblower lawyers who know laboratory compensation cases.

Can a Physician Have a Urine Drug Testing Lab in the Office?

In-office laboratories are common, and the referral-bonus question is how testing revenue reaches the physician’s pay. We look at who orders, who performs the test and who bills.

The physician’s employer, the testing location and the billing business each supply part of the explanation. We connect those relationships to the services credited in the bonus calculation.

When Are Toxicology Tests Unnecessary?

Toxicology tests are unnecessary when the testing exceeds what the patient’s clinical circumstances support. In the Advanced Pain settlement, the government’s allegation was that confirmatory orders went beyond patients’ individual risks and needs. In Family Medicine Centers, the alleged standing orders made the schedule drive testing instead of clinical need.

The clinical purpose is specific. Ethical Perspectives on Urine Drug Screening for Pain Physicians, published in Pain Physician in 2014, described testing to monitor adherence to prescribed medication and detect other drug use. The paper also explained how detection changes with the drug and the patient’s dosing history:

That is the clinical question a bonus spreadsheet cannot answer. The patient’s history, medication and reason for the particular test belong beside the laboratory order. We examine those choices alongside any financial instruction to increase testing.

What Evidence Is Needed to Prove Fraud?

Evidence connects the compensation promise to the orders, claims and payments it produced. We work with you to trace that connection, from the employment agreement and bonus calculation to the laboratory bill.

The payer matters, too. Labsource’s admitted arrangement illustrates why commercial receipts may explain a federal referral. Management’s instructions can explain why the formula was built that way.

An employed physician may know what management urged them to order. A practice manager or laboratory biller may see the instructions, test records and claims. That inside knowledge helps us build the whistleblower case around what the business actually did.

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

Physician Lab-Referral Bonus Whistleblower Experts

If you know which tests increased a physician’s pay, speak with our whistleblower experts about the compensation arrangement. We build the case with you around the formula, the referrals and the claims, and bring in laboratory fraud whistleblower lawyers who understand physician compensation. You have our expertise and partnership from the first account of the arrangement through the case.